184 related articles for article (PubMed ID: 35380056)
1. Hepatic fibrosis changes in patients with chronic hepatitis C infection who respond to direct-acting antivirals.
Alswat K; Al-Sohaibani F; Khathlan A; Bashmail A; Alanazi M; Kurdi A; Almakadma AH; Al-Hamoudi W
Ann Saudi Med; 2022; 42(2):89-95. PubMed ID: 35380056
[TBL] [Abstract][Full Text] [Related]
2. Improvement of liver stiffness measurement, acoustic radiation force impulse measurements, and noninvasive fibrosis markers after direct-acting antivirals for hepatitis C virus G4 recurrence post living donor liver transplantation: Egyptian cohort.
Alem SA; Said M; Anwar I; Abdellatif Z; Elbaz T; Eletreby R; AbouElKhair M; El-Serafy M; Mogawer S; El-Amir M; El-Shazly M; Hosny A; Yosry A
J Med Virol; 2018 Sep; 90(9):1508-1515. PubMed ID: 29718546
[TBL] [Abstract][Full Text] [Related]
3. Early fibrosis regression by shear wave elastography after successful direct-acting anti-HCV therapy.
Kohla MAS; Fayoumi AE; Akl M; Abdelkareem M; Elsakhawy M; Waheed S; Abozeid M
Clin Exp Med; 2020 Feb; 20(1):143-148. PubMed ID: 31792631
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Measurements Predict Liver Fibrosis Well in Hepatitis C Virus Patients After Direct-Acting Antiviral Therapy.
Huang R; Rao H; Yang M; Gao Y; Wang J; Jin Q; Ma D; Wei L
Dig Dis Sci; 2020 May; 65(5):1491-1500. PubMed ID: 31654313
[TBL] [Abstract][Full Text] [Related]
5. Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters.
Ferreira J; Bicho M; Serejo F
Viruses; 2024 Feb; 16(3):. PubMed ID: 38543737
[TBL] [Abstract][Full Text] [Related]
6. Direct antiviral agent treatment leads to rapid and significant fibrosis regression after HCV eradication.
Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
J Viral Hepat; 2021 Sep; 28(9):1284-1292. PubMed ID: 34105867
[TBL] [Abstract][Full Text] [Related]
7. Changes in Liver Stiffness and Noninvasive Fibrosis Scores in Egyptian Adolescents Successfully Treated with Ledipasvir-Sofosbuvir for Chronic Hepatitis C Virus Infection.
Fahmy DM; Shokeir M; El Zeiny SM; Jonas MM; Abdallah A
J Pediatr; 2021 Apr; 231():110-116. PubMed ID: 33347957
[TBL] [Abstract][Full Text] [Related]
8. Regression in hepatic fibrosis in elderly Chinese patients with hepatitis C receiving direct-acting antiviral treatment.
Niu B; Zang W; Zhou H; Mi Y; Lu C; Li P
BMC Gastroenterol; 2023 Apr; 23(1):102. PubMed ID: 37013471
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods.
Omar H; Said M; Eletreby R; Mehrez M; Bassam M; Abdellatif Z; Hosny A; Megawer S; El Amir M; Yosry A
Clin Transplant; 2018 Aug; 32(8):e13334. PubMed ID: 29935046
[TBL] [Abstract][Full Text] [Related]
10. DAAs therapy associated with improved hepatic fibrosis in HCV-GT4 patients co-infected with HIV.
El-Garem H; AbdAllah M; Omar H; Cordie A; Abdel Alem S; Mohey Eldin Elzahry MA; Ghaith D; Abou El-Soud NH; Kamal W; Elsharkawy A; Esmat G
Expert Rev Gastroenterol Hepatol; 2019 Jul; 13(7):693-698. PubMed ID: 31043104
[No Abstract] [Full Text] [Related]
11. Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection.
Degasperi E; D'Ambrosio R; Iavarone M; Sangiovanni A; Aghemo A; Soffredini R; Borghi M; Lunghi G; Colombo M; Lampertico P
Clin Gastroenterol Hepatol; 2019 May; 17(6):1183-1191.e7. PubMed ID: 30613002
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis C virus genotype-4 eradication following direct acting antivirals on liver stiffness measurement.
Tag-Adeen M; Sabra AM; Akazawa Y; Ohnita K; Nakao K
Hepat Med; 2017; 9():45-53. PubMed ID: 29062242
[TBL] [Abstract][Full Text] [Related]
13. Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients.
Laguno M; Martínez-Rebollar M; Casanova M; de Lazzari E; González-Cordón A; Torres B; Inciarte A; Mora L; Ugarte A; Ambrosioni J; Blanco JL; Martínez E; Mallolas J
Clin Microbiol Infect; 2022 Apr; 28(4):610.e1-610.e7. PubMed ID: 34464735
[TBL] [Abstract][Full Text] [Related]
14. Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis-4 score and aspartate aminotransferase-platelet ratio index.
Bachofner JA; Valli PV; Kröger A; Bergamin I; Künzler P; Baserga A; Braun D; Seifert B; Moncsek A; Fehr J; Semela D; Magenta L; Müllhaupt B; Terziroli Beretta-Piccoli B; Mertens JC
Liver Int; 2017 Mar; 37(3):369-376. PubMed ID: 27678216
[TBL] [Abstract][Full Text] [Related]
15. Improvement in Liver Stiffness in Pediatric Patients with Hepatitis C Virus after Treatment with Direct Acting Antivirals.
Mogahed EA; El-Karaksy H; Abdullatif H; Yasin NA; Nagy A; Alem SA; Eldeen HG; El-Raziky MS
J Pediatr; 2021 Jun; 233():126-131. PubMed ID: 33577805
[TBL] [Abstract][Full Text] [Related]
16. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents.
Hsu WF; Lai HC; Su WP; Lin CH; Chuang PH; Chen SH; Chen HY; Wang HW; Huang GT; Peng CY
BMC Gastroenterol; 2019 Apr; 19(1):63. PubMed ID: 31029101
[TBL] [Abstract][Full Text] [Related]
17. Indirect serum fibrosis markers in hepatitis C virus (HCV) infection.
Paunovic K; Stojanovic M; Dimitrijevic Z; Paunovic G; Djordjevic V; Konstantinovic L; Kostic S
Med Arch; 2012; 66(4):226-30. PubMed ID: 22919875
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis scores that can be used in follow-up of after direct-acting antiviral treatment: APRI, FIB-4, King score and GUCI.
Tahtasakal CA; Oncul A; Sevgi DY; Demirbas D; Gunduz A; Dokmetas I
Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):308-315. PubMed ID: 34091480
[TBL] [Abstract][Full Text] [Related]
19. Does fibrosis really regress in HIV/hepatitis C virus co-infected patients after treatment with direct antiviral agents?
Rial-Crestelo D; Sepúlveda MA; González-Gasca FJ; Geijo-Martínez P; Martínez-Alfaro E; Barberá JR; Yzusqui M; Casallo S; García M; Hornero CM; Espinosa-Gimeno A; Torralba M
AIDS; 2020 Mar; 34(3):427-432. PubMed ID: 31996593
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
